Literature DB >> 7139237

Regional lung ventilation in ankylosing spondylitis.

A Parkin, P J Robinson, P Hickling.   

Abstract

Patients with ankylosing spondylitis (AS) sometimes develop apical lung fibrosis and cavitation. It has been suggested that one causative factor is reduced apical ventilation due to rigidity of the thoracic cage. We measured regional ventilation in 27 patients with AS and 18 normal volunteers. Twelve patients (Group A) had chest expansion greater than 2 cm, twelve (Group B) had chest expansion of 2 cm or less and three (Group C) had apical lung lesions on chest radiographs; patients in Groups A and B had no radiographic lung lesions. Ventilation per unit volume (VE/VA min-1) was calculated from 81Krm washout curves. The ratio of upper zone to lower zone ventilation (VR) was calculated. VR in Group A (0.74 +/- 0.11) and group B (0.75 +/- 0.12) was not significantly different from VR in controls (0.76 +/- 0.08). There was no significant correlation between VR and FVC, FEV1 or maximal chest expansion. In patients with apical fibrosis only the radiographically abnormal areas had reduced ventilation. Patients with AS do not underventilate the upper zones of the lungs except in the presence of radiographically visible fibrosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139237     DOI: 10.1259/0007-1285-55-659-833

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

1.  Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis.

Authors:  L R Fisher; M I Cawley; S T Holgate
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

2.  Pulmonary involvement in ankylosing spondylitis.

Authors:  Percival D Sampaio-Barros; Elza Maria F P Cerqueira; Sílvio M Rezende; Lucimara Maeda; Roseneide A Conde; Verônica A Zanardi; Manoel Barros Bértolo; José Ribeiro de Menezes Neto; Adil M Samara
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

Review 3.  Pulmonary manifestations of the rheumatic diseases.

Authors:  D W Boulware; D N Weissman; N J Doll
Journal:  Clin Rev Allergy       Date:  1985-05

4.  Clearance of inhaled particles in ankylosing spondylitis.

Authors:  D R Farquhar; M J Chamberlain; G A McCain; W K Morgan
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.